Very recently, Suzuki et al. [37] reported about SFRP2 methylation in human breast cancer, and their study demonstrated an inhibitory effect of SFRP2 on canonical Wnt signaling in breast cancer cell lines. Here, SFRP2 is linked to breast cancer.